Neose Technologies Presents Positive NE-180 Phase I Clinical Trial Data at American Society of Hematology Annual Meeting HORSHAM, Pa -- Neose Technologies, Inc. presented positive data from its NE-180 ...
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback